Co-Expression Network Approach to Studying the Effects of Botulinum Neurotoxin-A

Botulinum Neurotoxin A (BoNT-A) is a potent neurotoxin with several clinical applications. The goal of this study was to utilize co-expression network theory to analyze temporal transcriptional data from skeletal muscle after BoNT-A treatment. Expression data for 2000 genes (extracted using a ranking heuristic) served as the basis for this analysis. Using weighted gene co-expression network analysis (WGCNA), we identified 19 co-expressed modules, further hierarchically clustered into five groups. Quantifying average expression and co-expression patterns across these groups revealed temporal aspects of muscle's response to BoNT-A. Functional analysis revealed enrichment of group 1 with metabolism; group 5 with contradictory functions of atrophy and cellular recovery; and groups 2 and 3 with extracellular matrix (ECM) and non-fast fiber isoforms. Topological positioning of two highly ranked, significantly expressed genes—Dclk1 and Ostalpha—within group 5 suggested possible mechanistic roles in recovery from BoNT-A induced atrophy. Phenotypic correlations of groups with titin and myosin protein content further emphasized the effect of BoNT-A on the sarcomeric contraction machinery in early phase of chemodenervation. In summary, our approach revealed a hierarchical functional response to BoNT-A induced paralysis with early metabolic and later ECM responses and identified putative biomarkers associated with chemodenervation. Additionally, our results provide an unbiased validation of the response documented in our previous work.

[1]  S. Priori,et al.  Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin , 2004, Circulation research.

[2]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[3]  A. G. de la Fuente From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases. , 2010, Trends in genetics : TIG.

[4]  Helena Brentani,et al.  Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia , 2015, BMC Medical Genomics.

[5]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[6]  Jihua Fan,et al.  Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. , 2005, Genes & development.

[7]  E. Senba,et al.  In Vivo Activation of STAT3 Signaling in Satellite Cells and Myofibers in Regenerating Rat Skeletal Muscles , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[9]  G. Schiavo,et al.  Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission , 2002, Journal of Physiology-Paris.

[10]  A. Straube,et al.  Time course of distant effects of local injections of botulinum toxin , 1993, Movement disorders : official journal of the Movement Disorder Society.

[11]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[12]  R. Lieber,et al.  Systematic test of neurotoxin dose and volume on muscle function in a rat model , 2014, Muscle & nerve.

[13]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[14]  Hui Liu,et al.  AnimalTFDB: a comprehensive animal transcription factor database , 2011, Nucleic Acids Res..

[15]  M. Jackson,et al.  C-myc is expressed in mouse skeletal muscle nuclei during post-natal maturation. , 1998, The international journal of biochemistry & cell biology.

[16]  D. Geschwind,et al.  A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging , 2008, The Journal of Neuroscience.

[17]  Thomas L. Smith,et al.  Gene expression of nAChR, SNAP‐25 and GAP‐43 in skeletal muscles following botulinum toxin A injection: A study in rats , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[18]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[19]  Richard G. Taylor,et al.  Differential proteome analysis of aging in rat skeletal muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  R. Lieber,et al.  Recovery of rat muscle size but not function more than 1 year after a single botulinum toxin injection , 2018, Muscle & nerve.

[21]  Cristóbal Fresno,et al.  RDAVIDWebService: a versatile R interface to DAVID , 2013, Bioinform..

[22]  Yi-Ning Wu,et al.  Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters. , 2008, Archives of physical medicine and rehabilitation.

[23]  S. Hubbard,et al.  Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK , 2008, Cell.

[24]  R. Spielman,et al.  expression reveals gene interactions and functions Coexpression network based on natural variation in human gene Material , 2009 .

[25]  Dragica Radojkovic,et al.  Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease , 2011, Critical reviews in clinical laboratory sciences.

[26]  G. Rodney,et al.  Does a lack of RyR3 make mammalian skeletal muscle EC coupling a ‘spark‐less’ affair? , 2008, The Journal of physiology.

[27]  A. Cumano,et al.  An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells. , 2010, Stem cell research.

[28]  J. Gracies Physiological effects of botulinum toxin in spasticity , 2004, Movement disorders : official journal of the Movement Disorder Society.

[29]  D. Hood,et al.  Coordination of metabolic plasticity in skeletal muscle , 2006, Journal of Experimental Biology.

[30]  Thomas L. Smith,et al.  Time Course of Recovery of Juvenile Skeletal Muscle After Botulinum Toxin A Injection: An Animal Model Study , 2004, American journal of physical medicine & rehabilitation.

[31]  L. Simpson,et al.  Identification of the major steps in botulinum toxin action. , 2004, Annual review of pharmacology and toxicology.

[32]  C. Walsh,et al.  Genetic Interactions between Doublecortin and Doublecortin-like Kinase in Neuronal Migration and Axon Outgrowth , 2006, Neuron.

[33]  Thomas L. Smith,et al.  How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  Kewei Ma,et al.  STAT3 induces muscle stem cell differentiation by interaction with myoD. , 2009, Cytokine.

[35]  M. Woo,et al.  Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy. , 2009, Journal of applied physiology.

[36]  T. Lømo,et al.  A Novel Role for Embigin to Promote Sprouting of Motor Nerve Terminals at the Neuromuscular Junction* , 2009, Journal of Biological Chemistry.

[37]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[38]  Leonard A. Smith,et al.  Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A , 2003, The Journal of Biological Chemistry.

[39]  D L Kirkpatrick,et al.  Disruption of a Single Copy of the SERCA2 Gene Results in Altered Ca2+ Homeostasis and Cardiomyocyte Function* , 2000, The Journal of Biological Chemistry.

[40]  B. Engels,et al.  A potential role for calcium / calmodulin‐dependent protein kinase‐related peptide in neuronal apoptosis: in vivo and in vitro evidence , 2007, The European journal of neuroscience.

[41]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Yixue Li,et al.  Identifying Modules of Coexpressed Transcript Units and Their Organization of Saccharopolyspora erythraea from Time Series Gene Expression Profiles , 2010, PloS one.

[43]  S. Ovsepian,et al.  Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics. , 2009, Current opinion in pharmacology.

[44]  R. Rosales,et al.  Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity , 2008, Journal of Neural Transmission.

[45]  Amy M Lang Focused review: Botulinum toxin type A therapy in chronic pain disorders , 2003 .

[46]  R. Lieber,et al.  Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin , 2014, Muscle & nerve.

[47]  S. Kandarian,et al.  The molecular basis of skeletal muscle atrophy. , 2004, American journal of physiology. Cell physiology.

[48]  A. D’Alessandro,et al.  Absence of Aquaporin-4 in Skeletal Muscle Alters Proteins Involved in Bioenergetic Pathways and Calcium Handling , 2011, PloS one.

[49]  J. Boyer,et al.  OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids. , 2009, Frontiers in bioscience.

[50]  Terence P. Speed,et al.  On Gene Ranking Using Replicated Microarray Time Course Data , 2009, Biometrics.

[51]  Steve Horvath,et al.  Adipose Co-expression networks across Finns and Mexicans identify novel triglyceride-associated genes , 2012, BMC Medical Genomics.

[52]  L. Tsai,et al.  Doublecortin-like Kinase Controls Neurogenesis by Regulating Mitotic Spindles and M Phase Progression , 2006, Neuron.

[53]  N. Ruderman,et al.  Glucose uptake and insulin sensitivity in rat muscle: changes during 3-96 weeks of age. , 1983, The American journal of physiology.